The cancer metabolic reprogramming and immune response
نویسندگان
چکیده
منابع مشابه
Cancer Metabolic and Immune Reprogramming: The Intimate Interaction Between Cancer Cells and Microenvironment
ECM: Extracellular Matrix; CAFs: Cancer Associated Fibroblasts; TLRs: Toll-like Receptors; Ig: Immunoglobulin; RAG: Recombination Activating Genes; TCA: Tri Carboxylic Acid; MCT: Monocarboxylate Transporter; ROS: Reactive Oxygen Species; HK2: Hexokinase 2; PET: Positron Emission Tomography; PFK-1: 6-Phosphofructo-1-Kinase; PK: Pyruvate Kinase; SPs: Specificity Proteins; GFs: Growth Factors; PDG...
متن کاملSimilarities in the Metabolic Reprogramming of Immune System and Endothelium
Cellular metabolism has been known for its role in bioenergetics. In recent years, much light has been shed on the reprogrammable cellular metabolism underlying many vital cellular processes, such as cell activation, proliferation, and differentiation. Metabolic reprogramming in immune and endothelial cells (ECs) is being studied extensively. These cell compartments are implicated in inflammati...
متن کاملOxygen availability and metabolic reprogramming in cancer.
Hypoxia and dysregulated metabolism are defining features of solid tumors. How cancer cells adapt to low O2 has been illuminated by numerous studies, with "reprogrammed" metabolism being one of the most important mechanisms. This metabolic reprogramming not only promotes cancer cell plasticity, but also provides novel insights for treatment strategies. As the most studied O2 "sensor," hypoxia-i...
متن کاملDysregulated metabolic enzymes and metabolic reprogramming in cancer cells
Tumor cells carry various genetic and metabolic alterations, which directly contribute to their growth and malignancy. Links between metabolism and cancer are multifaceted. Metabolic reprogramming, such as enhanced aerobic glycolysis, mutations in the tricarboxylic acid (TCA) cycle metabolic enzymes, and dependence on lipid and glutamine metabolism are key characteristics of cancer cells. Under...
متن کاملImmunotherapy of Cancer: Reprogramming Tumor-Immune Crosstalk
The advancement of cancer immunotherapy faces barriers which limit its efficacy. These include weak immunogenicity of the tumor, as well as immunosuppressive mechanisms which prevent effective antitumor immune responses. Recent studies suggest that aberrant expression of cancer testis antigens (CTAs) can generate robust antitumor immune responses, which implicates CTAs as potential targets for ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Molecular Cancer
سال: 2021
ISSN: 1476-4598
DOI: 10.1186/s12943-021-01316-8